Loading…
Held by equity mutual funds in 33 disclosed months, Jan 2015 to Sep 2026.
Caplin Point Laboratories Limited (Pharmaceuticals & Biotechnology) was held by 6 active equity mutual funds in September 2026, ₹217 Cr in all (up 0 funds from Aug 2026). The largest position was UTI - Healthcare Fund at 3.0% of its portfolio. During the month 1 fund entered and 1 exited. Funds have disclosed holding it since Jan 2015.
Weight is the share of that fund's portfolio; change is against the previous disclosed month.
How many equity funds held the company each month, and the value they held.